Free shipping on all orders over $ 500

AH-7614

Cat. No. M22486

All AbMole products are for research use only, cannot be used for human consumption.

AH-7614 Structure
Synonym:

AH7614

Size Price Availability Quantity
2mg USD 33 In stock
5mg USD 47 In stock
10mg USD 83 In stock
25mg USD 176 In stock
50mg USD 278 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AH-7614 is a potent and selective FFA4 (GPR120) antagonist, with pIC50s of 7.1, 8.1, and 8.1 for human, mouse, and rat FFA4, respectively. AH-7614 has selectivity for FFA4 over FFA1 (pIC50<4.6). AH-7614 is able to block effects of both the polyunsaturated ω-6 fatty acid linoleic acid and the synthetic FFA4 agonist. AH-7614 (0.063-1 μM) blocks intracellular Ca2+ response induced by both linoleic acid and FFAR4 agonist in FFA4 expressing U2OS cells.

AH7614 (50 μg; intratumoral injection one day prior to epirubicin injection) enhances cancer cell sensitivity to the chemotherapy and inhibit tumor progression by blocking GPR120 signaling in combination with Epirubicin.

Chemical Information
Molecular Weight 351.42
Formula C20H17NO3S
CAS Number 6326-06-3
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Chao-Ping Wang, et al. J Nutr Biochem. Differential effects of EPA and DHA on PPARγ-mediated sympathetic innervation in infarcted rat hearts by GPR120-dependent and -independent mechanisms

[2] Wei-Ting Chen, et al. J Cell Mol Med. Effect of icosapent ethyl on susceptibility to ventricular arrhythmias in postinfarcted rat hearts: Role of GPR120-mediated connexin43 phosphorylation

[3] Yeeun Park, et al. Genes Nutr. Docosahexaenoic acid inhibits zymogen activation by suppressing vacuolar ATPase activation in cerulein-stimulated pancreatic acinar cells

[4] A G McCloskey, et al. Eur J Pharm Sci. Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis

[5] Kenneth R Watterson, et al. Mol Pharmacol. Probe-Dependent Negative Allosteric Modulators of the Long-Chain Free Fatty Acid Receptor FFA4

Related GPR/FFAR Products
GW9508

GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 has anti-inflammatory and anti-atherosclerotic activities. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener.

Fasiglifam (TAK-875) Hemihydrate

Fasiglifam (TAK-875) Hemihydrate is a novel, orally available, selective GPR40 agonist.

OC000459

OC000459 is a potent, selective, and orally active D prostanoid receptor 2 antagonist.

AMG-837

AMG 837 is a potent, orally bioavailable GPR40 agonist with EC50 of 14 nM.

AZD1981

AZD1981 is a potent, selective CRTh2 (DP2) receptor antagonist with IC50 of 4 nM, showing >1000-fold selectivity over more than 340 other enzymes and receptors, including DP1.

  Catalog
Abmole Inhibitor Catalog




Keywords: AH-7614, AH7614 supplier, GPR/FFAR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.